Glaucoma is one of the leading causes of blindness within the United States (Mayo Clinic, 2015). This condition is seen as a group of eye conditions that can cause damage to the optic nerve and cause vision loss.
This damage is usually caused by unusually high intraocular pressure (NEI, n.d.). Because high Thc gummies pressure is a known major risk factor that can be controlled (Prum et al., 2016, p. 52), many therapies are designed to reduce it. Studies suggest that cannabinoids may be effective as an effective treatment for reducing eye pressure (Tomida et al., 2007).
- Is Cannabis or
- Cannabinoids An
- Effective Treatment of
- Glaucoma
Systematic Review
We have identified a systematic review of one quality (Whiting et al., 2015) that evaluated medical marijuana for the treatment of glaucoma. This review identified one randomized crossover trial (six participants) in patients with glaucoma.
The tests compared THC (5 mg oromucosal spray), cannabidiol (20 mg oromucosal spray), cannabidiol spray (40 mg oromucosal spray), and placebo, which monitors intraocular pressure periodically for up to 12 hours after treatment. High intraocular Weed gummies is one of the diagnostic criteria for glaucoma, and lowering intraocular pressure is the goal of treating glaucoma (Prum et al., 2016).
The case has been evaluated as a “clear” risk of bias. No differences in intraocular pressure were found between placebo and cannabinoids.
Basic Texts
The committee did not identify any of the best quality literature reporting medical marijuana as an effective treatment for glaucoma symptoms and published after a period of good or appropriate systematic review of recently published quality reviews. research question.
Discussion of Results
Low intraocular pressure is the main goal of glaucoma treatment. Randomized studies in healthy Cannabis gummies and glaucoma patients showed short-term reductions in oral intraocular pressure, topical eye drops, and intravenous cannabinoids, suggesting possible therapeutic benefits (IOM, 1999, pp. 174-175 ).
A systematic review of good quality identified one small trial that did not receive the effect of two cannabinoids, given as an oromucosal spray, at intraocular pressure (Whiting et al., 2015).
The level of evidence
Of finding no effect is limited. However, in order to be effective, treatment directed at low intraocular pressure must provide continuous rather than a temporary reduction in intraocular pressure.
To date, those studies that show positive results have shown only a temporary benefit to Cannabis edible pressure (hours), which raises the limited potential of cannabinoids in the treatment of glaucoma.
HEAVY DANGEROUS INJURY / INTERNAL BLOOD
Traumatic brain injury (TBI) diagnosed brain damage that can result from sudden or violent headaches (NINDS, 2016c). TBI accounts for about 30 percent of all casualties in the United States (CDC, 2016).
- Intracranial hemorrhage (ICH), hemorrhage
- That occurs within the skull, is a common
- Complication of TBI associated
- With severe prognosis of injury
There is a body of literature reporting neuroprotective effects of cannabinoid analogue in pre-traumatic studies (Mechoulam et al., 2002) and in observational studies (Di Napoli et al., 2016; Nguyen et al., 2014).
